Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Dianna Quan

Concepts (162)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Polyneuropathies
7
2022
50
1.960
Why?
Muscular Atrophy, Spinal
2
2021
17
1.330
Why?
Amyloid Neuropathies, Familial
3
2022
8
1.250
Why?
Motor Neuron Disease
2
2021
16
0.860
Why?
Amyotrophic Lateral Sclerosis
2
2021
61
0.830
Why?
Neural Conduction
4
2018
79
0.810
Why?
Point Mutation
2
2016
218
0.720
Why?
Muscle, Skeletal
3
2019
1459
0.710
Why?
Muscle Weakness
4
2018
81
0.670
Why?
Myositis
1
2019
43
0.650
Why?
Prealbumin
3
2022
22
0.610
Why?
Neuromuscular Diseases
2
2008
90
0.580
Why?
Electromyography
5
2021
325
0.580
Why?
TRPV Cation Channels
1
2016
28
0.550
Why?
Critical Illness
3
2018
646
0.530
Why?
Biopsy
1
2019
1056
0.510
Why?
Polymyositis
1
2011
14
0.390
Why?
Muscular Dystrophies
1
2011
36
0.380
Why?
Pain
1
2016
713
0.370
Why?
Multiple Sclerosis
2
2005
380
0.360
Why?
Intensive Care Units
6
2018
616
0.360
Why?
Electrodiagnosis
2
2012
15
0.350
Why?
Receptors, Cholinergic
1
2008
41
0.320
Why?
Nervous System Diseases
1
2011
253
0.310
Why?
Diagnostic Errors
1
2008
151
0.300
Why?
Patient Discharge
3
2018
770
0.290
Why?
Diagnosis, Differential
4
2016
1358
0.280
Why?
Antibodies
1
2008
374
0.280
Why?
Neuralgia, Postherpetic
1
2006
44
0.270
Why?
Valine
1
2006
74
0.270
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2005
4
0.260
Why?
Acyclovir
1
2006
100
0.260
Why?
Spinal Nerve Roots
1
2005
30
0.260
Why?
Cranial Nerve Diseases
1
2005
42
0.250
Why?
Neuralgia
2
2021
122
0.240
Why?
Peripheral Nervous System Diseases
1
2005
120
0.240
Why?
Myasthenia Gravis
1
2023
18
0.230
Why?
Activities of Daily Living
2
2023
352
0.220
Why?
Ketamine
1
2003
91
0.200
Why?
Humans
25
2023
115890
0.200
Why?
Nortriptyline
1
2021
5
0.190
Why?
Duloxetine Hydrochloride
1
2021
8
0.190
Why?
Aged
10
2021
19296
0.190
Why?
Sural Nerve
2
2014
19
0.180
Why?
Antiviral Agents
1
2006
648
0.180
Why?
Analgesics
1
2021
157
0.170
Why?
Motor Neurons
1
2021
213
0.170
Why?
Herpes Zoster
1
2003
333
0.160
Why?
RNA, Small Interfering
1
2020
546
0.160
Why?
Adult
10
2021
30814
0.150
Why?
Female
16
2021
60076
0.150
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
242
0.150
Why?
Middle Aged
11
2021
27080
0.150
Why?
Pain Management
1
2021
291
0.150
Why?
Male
15
2021
56123
0.150
Why?
Rhabdomyolysis
1
2015
16
0.130
Why?
Patient Outcome Assessment
1
2016
123
0.130
Why?
Aged, 80 and over
3
2019
6437
0.120
Why?
Treatment Outcome
3
2022
9165
0.120
Why?
Sensitivity and Specificity
1
2019
1728
0.120
Why?
Physical Exertion
1
2015
208
0.120
Why?
Peroneal Nerve
1
2014
19
0.120
Why?
Prospective Studies
4
2018
6266
0.120
Why?
Neurologic Examination
1
2014
117
0.110
Why?
Electrophysiology
1
2014
202
0.110
Why?
Muscle Strength
1
2016
278
0.110
Why?
Muscular Diseases
2
2017
104
0.110
Why?
Quality of Life
2
2022
2391
0.110
Why?
Biomarkers
1
2022
3473
0.100
Why?
Bed Rest
1
2012
15
0.100
Why?
Immunoglobulins
2
2009
148
0.100
Why?
Antibodies, Monoclonal
2
2023
1262
0.090
Why?
Phenotype
2
2016
2858
0.090
Why?
Physical Examination
1
2011
224
0.090
Why?
Meningoencephalitis
1
2009
24
0.080
Why?
West Nile Fever
1
2009
50
0.080
Why?
Retrospective Studies
3
2019
12616
0.080
Why?
Physical Therapy Modalities
1
2012
270
0.080
Why?
Frontal Lobe
1
2010
140
0.080
Why?
Respiration, Artificial
3
2018
525
0.080
Why?
Electrodes
1
2008
99
0.080
Why?
Sepsis
1
2014
519
0.080
Why?
Psychiatric Status Rating Scales
1
2010
485
0.070
Why?
Immunocompromised Host
1
2009
197
0.070
Why?
Immunologic Factors
1
2009
219
0.070
Why?
Lung Transplantation
1
2009
245
0.070
Why?
Glycogen Storage Disease Type IIb
1
2007
22
0.070
Why?
Young Adult
2
2019
10515
0.070
Why?
Injections, Intravenous
1
2006
204
0.070
Why?
Peripheral Nervous System
1
2005
18
0.070
Why?
Cognition Disorders
1
2010
479
0.060
Why?
Action Potentials
1
2008
408
0.060
Why?
Guillain-Barre Syndrome
1
2005
21
0.060
Why?
Cranial Nerves
1
2005
11
0.060
Why?
Executive Function
1
2010
374
0.060
Why?
Neuropsychological Tests
1
2010
932
0.060
Why?
Nerve Fibers, Myelinated
1
2005
41
0.060
Why?
Exercise
1
2015
1610
0.060
Why?
Graves Disease
1
2005
32
0.060
Why?
Hypertrophy
1
2005
112
0.060
Why?
Adolescent
3
2019
17949
0.060
Why?
Nerve Tissue Proteins
1
2008
538
0.060
Why?
Friedreich Ataxia
1
2005
64
0.060
Why?
Evidence-Based Medicine
1
2008
686
0.060
Why?
Treatment Failure
1
2005
333
0.060
Why?
Administration, Oral
1
2006
731
0.060
Why?
Cardiomyopathy, Dilated
1
2007
352
0.060
Why?
Myelin Sheath
1
2005
146
0.060
Why?
Central Nervous System
1
2005
239
0.060
Why?
Axons
1
2005
180
0.060
Why?
Drug Evaluation
1
2003
79
0.060
Why?
Drug Therapy, Combination
1
2006
961
0.050
Why?
Administration, Cutaneous
1
2003
116
0.050
Why?
Gels
1
2003
72
0.050
Why?
Carpal Tunnel Syndrome
1
2002
27
0.050
Why?
Patients
1
2023
164
0.050
Why?
North America
1
2002
262
0.050
Why?
Analgesics, Non-Narcotic
1
2003
117
0.050
Why?
Pregabalin
1
2021
9
0.050
Why?
Mexiletine
1
2021
7
0.050
Why?
Immunosuppressive Agents
1
2005
666
0.050
Why?
Comparative Effectiveness Research
1
2021
130
0.040
Why?
Infusions, Intravenous
1
2020
374
0.040
Why?
Bayes Theorem
1
2021
336
0.040
Why?
Severity of Illness Index
2
2020
2598
0.040
Why?
Hospital Charges
1
2017
39
0.040
Why?
Propensity Score
1
2017
225
0.030
Why?
APACHE
1
2016
58
0.030
Why?
Electrophysiological Phenomena
1
2016
47
0.030
Why?
Autoantibodies
1
2023
1362
0.030
Why?
Creatine Kinase
1
2015
72
0.030
Why?
Ultrasonography
1
2018
671
0.030
Why?
Magnetic Resonance Imaging
1
2005
3086
0.030
Why?
Brain
1
2005
2382
0.030
Why?
Hospital Mortality
1
2017
784
0.030
Why?
Length of Stay
1
2017
963
0.030
Why?
Logistic Models
1
2017
1865
0.030
Why?
Patient Readmission
1
2017
607
0.030
Why?
Respiratory Muscles
1
2012
32
0.030
Why?
Mobility Limitation
1
2012
60
0.020
Why?
Muscular Atrophy
1
2012
76
0.020
Why?
Predictive Value of Tests
1
2016
1817
0.020
Why?
Muscle Fatigue
1
2012
86
0.020
Why?
Disability Evaluation
1
2012
273
0.020
Why?
Child
1
2008
18550
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2009
80
0.020
Why?
Colorado
1
2018
4122
0.020
Why?
Cohort Studies
1
2018
4961
0.020
Why?
Fatal Outcome
1
2009
286
0.020
Why?
Rituximab
1
2009
149
0.020
Why?
alpha 1-Antitrypsin Deficiency
1
2009
79
0.020
Why?
Time Factors
1
2017
6186
0.020
Why?
Lysosomal-Associated Membrane Protein 2
1
2007
26
0.020
Why?
Graft Rejection
1
2009
533
0.020
Why?
Pedigree
1
2007
474
0.020
Why?
Pilot Projects
1
2010
1374
0.020
Why?
Algorithms
1
2012
1493
0.020
Why?
B-Lymphocytes
1
2009
770
0.010
Why?
Prognosis
1
2012
3342
0.010
Why?
Disease Progression
1
2009
2424
0.010
Why?
Mutation
1
2007
3369
0.010
Why?
Infant
1
2007
8002
0.010
Why?
Quan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)